Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
International Journal of Clinical Oncology|January 12, 2025
Transforming cancer screening: the potential of multi-cancer early detection (MCED) technologiesMitsuho Imai, Yoshiaki Nakamura, Takayuki YoshinoOncology Reports|October 20, 2004
Infrequent somatic mutations of the ICAT gene in various human cancers with frequent 1p-LOH and/or abnormal nuclear accumulation of beta-cateninMitsuho Imai, Tsutomu Nakamura, Tetsu Akiyama, et al.Cellular and Molecular Life Sciences : CMLS|August 26, 2017
Interaction and cross-talk between non-coding RNAsSoichiro Yamamura, Mitsuho Imai-Sumida, Yuichiro Tanaka, et al.European Journal of Gastroenterology & Hepatology|October 22, 2008
Serum IgG4 levels and extrapancreatic lesions in autoimmune pancreatitisTerumi Kamisawa, Mitsuho Imai, Naoto Egawa, et al.Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 8, 2020
[Learning from My Experience: Outpatient Care for Cancer Multigene Genomic Testing]Eriko Aimono, Aki Iguchi, Kaori Mochida, et al.Diagnostic Pathology|May 30, 2020
Genetic profiling of patients with adenoid cystic carcinoma of the Bartholin's glands reveals potential new routes for targeted therapies: a case reportKohei Nakamura, Eriko Aimono, Shigeki Tanishima, et al.Oncotarget|December 2, 2017
Silibinin suppresses bladder cancer through down-regulation of actin cytoskeleton and PI3K/Akt signaling pathwaysMitsuho Imai-Sumida, Takeshi Chiyomaru, Shahana Majid, et al.Pancreas|September 26, 2008
Strategy for differentiating autoimmune pancreatitis from pancreatic cancerTerumi Kamisawa, Mitsuho Imai, Pong Yui Chen, et al.Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|January 22, 2020
Genistein Represses HOTAIR/Chromatin Remodeling Pathways to Suppress Kidney CancerMitsuho Imai-Sumida, Pritha Dasgupta, Priyanka Kulkarni, et al.Diagnostics (Basel, Switzerland)|April 9, 2020
Intratumoral Genomic Heterogeneity May Hinder Precision Medicine Strategies in Patients with Serous Ovarian CarcinomaKohei Nakamura, Eriko Aimono, Shigeki Tanishima, et al.Pageof 4